cgp 12177 has been researched along with Hypertension, Portal in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trebicka, J | 1 |
| Hennenberg, M | 1 |
| Schulze Pröbsting, A | 1 |
| Laleman, W | 1 |
| Klein, S | 1 |
| Granzow, M | 1 |
| Nevens, F | 1 |
| Zaagsma, J | 1 |
| Heller, J | 1 |
| Sauerbruch, T | 1 |
1 other study available for cgp 12177 and Hypertension, Portal
| Article | Year |
|---|---|
Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.
Topics: Animals; Cyclic AMP; Cyclic GMP-Dependent Protein Kinases; Hepatic Stellate Cells; Humans; Hypertens | 2009 |